You have read all your free articles, to continue reading subscribe to read the rest of this content.
Italian pharmaceutical company Chiesi Group has signed, through its UK affiliate, Chiesi Ltd., a definitive agreement with Sunstone Capital to acquire Zymenex Holding A/S and its related group of companies. Danish Zymenex is a biopharmaceutical group focused on research and development of innovatAlready a subscriber Login You have read all…
SynAct Pharma has entered into a conditional agreement on acquisition of TXP Pharma, a Swiss-incorporated biotech company researching and developing pharmaceutical drugs for the treatment of autoimmune and inflammatory diseases. The purchase price consists of a fixed purchase price of SEK 136 milAlready a subscriber Login You have read all…
Vännäs-based Agrisera has been acquired by Uppsala based biotech company Olink Proteomics. Agrisera is specializing in the production of polyclonal and monoclonal antibodies. The company provides a large range of ready-made antibodies, mainly for plant research, which are used, for example, to Already a subscriber Login You have read all…
Valo Therapeutics has announced the acquisition of intellectual property rights for the ‘PeptiBAC’ technology from the University of Helsinki, Finland. "We have a strong and enduring innovation partnership with the University of Helsinki, based on our PeptiCRAd and PeptiENV technologies. JustAlready a subscriber Login You have read all your free…
